ClinicalTrials.Veeva

Menu

Improving Metabolism With HDL Cholesterol

B

Bayside Health

Status

Completed

Conditions

Diabetes
Heart Disease

Treatments

Drug: rHDL

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

High levels of good cholesterol (HDL) in our blood decreases our chance of having a heart attack. This relates in part to the role good cholesterol plays in reducing build up of fat in the arteries. However, good cholesterol has many other protective effects. We have recently identified three enzymes (proteins) activated by HDL in cells lining the blood vessels, which may be responsible for some of HDL's protective actions.

Enrollment

13 patients

Sex

Male

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 18 - 65 years
  • Free of overt coronary disease
  • Body mass index <35 kg.m-2
  • Fasting plasma glucose > 7 mmol/L-1
  • No major illness

Exclusion criteria

  • Unable to give informed consent
  • Smokers
  • Abnormal LFT, U&E, FBE or creatinine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems